Methods of detection and removal of rhabdoviruses from cell lines

US11286282B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11286282-B2
Application numberUS-201916662784-A
CountryUS
Kind codeB2
Filing dateOct 24, 2019
Priority dateOct 3, 2013
Publication dateMar 29, 2022
Grant dateMar 29, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to compositions, methods, mixtures, and kits for detecting the presence of, and for removing, a virus from a product produced in an insect cell. The disclosure also relates to proteins, peptides, polypeptides, drug substances, biological products, vaccine antigens, and virus-like particles that are produced in an insect cell and that are free or substantially free of a virus. The disclosure also relates to compositions, methods, assays, and kits for detecting a rhabdovirus in a sample.

First claim

Opening claim text (preview).

What is claimed is: 1. A rhabdovirus-free Sf9 or Sf21 insect cell comprising a biological product. 2. The insect cell of claim 1 , wherein the insect cell is free of a nucleotide sequence having at least 70% homology to SEQ ID NO:1. 3. The insect cell of claim 1 , wherein the insect cell is an Sf9 cell. 4. The insect cell of claim 3 , wherein the Sf9 cell is derived from the cell line deposited as ATCC CRL-1711. 5. The insect cell of claim 1 , wherein the biological product is a protein, peptide, drug substance, virus-like particle (VLP), DNA, RNA, virus, or vaccine antigen. 6. The insect cell of claim 1 , wherein the biological product is a recombinant virus for gene therapy. 7. The insect cell of claim 1 , wherein the biological product is a protein or virus-like particle (VLP). 8. The insect cell of claim 1 , wherein the insect cell is free of a nucleotide sequence comprising the sequence according to SEQ ID NO: 1.

Assignees

Inventors

Classifications

  • Extraction; Separation; Purification · CPC title

  • C12Q1/701Primary

    Specific hybridization probes · CPC title

  • C12N7/00Primary

    Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title

  • Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein · CPC title

  • Methods of production or purification of viral material · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11286282B2 cover?
The present disclosure relates to compositions, methods, mixtures, and kits for detecting the presence of, and for removing, a virus from a product produced in an insect cell. The disclosure also relates to proteins, peptides, polypeptides, drug substances, biological products, vaccine antigens, and virus-like particles that are produced in an insect cell and that are free or substantially free…
Who is the assignee on this patent?
Takeda Vaccines Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/701. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).